Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CME vs CBOE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CME
CME Group Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$104.06B
5Y Perf.+57.1%
CBOE
Cboe Global Markets, Inc.

Financial - Data & Stock Exchanges

Financial ServicesAMEX • US
Market Cap$36.03B
5Y Perf.+223.1%

CME vs CBOE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CME logoCME
CBOE logoCBOE
IndustryFinancial - Data & Stock ExchangesFinancial - Data & Stock Exchanges
Market Cap$104.06B$36.03B
Revenue (TTM)$6.52B$4.71B
Net Income (TTM)$4.24B$1.10B
Gross Margin86.1%48.9%
Operating Margin64.9%32.1%
Forward P/E23.5x27.4x
Total Debt$3.76B$1.68B
Cash & Equiv.$4.42B$2.22B

CME vs CBOELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CME
CBOE
StockMay 20May 26Return
CME Group Inc. (CME)100157.1+57.1%
Cboe Global Markets… (CBOE)100323.1+223.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: CME vs CBOE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CBOE leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. CME Group Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
CME
CME Group Inc.
The Banking Pick

CME is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 6 yrs, beta -0.30, yield 3.8%
  • Lower volatility, beta -0.30, Low D/E 13.1%, current ratio 92.97x
  • Beta -0.30, yield 3.8%, current ratio 92.97x
Best for: income & stability and sleep-well-at-night
CBOE
Cboe Global Markets, Inc.
The Banking Pick

CBOE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 15.1%, EPS growth 44.5%
  • 476.8% 10Y total return vs CME's 289.3%
  • PEG 1.40 vs CME's 1.71
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCBOE logoCBOE15.1% NII/revenue growth vs CME's 6.4%
ValueCME logoCMELower P/E (23.5x vs 27.4x)
Quality / MarginsCBOE logoCBOEEfficiency ratio 0.2% vs CME's 0.2% (lower = leaner)
Stability / SafetyCME logoCMELower D/E ratio (13.1% vs 32.8%)
DividendsCME logoCME3.8% yield, 6-year raise streak, vs CBOE's 0.8%
Momentum (1Y)CBOE logoCBOE+49.7% vs CME's +5.5%
Efficiency (ROA)CBOE logoCBOEEfficiency ratio 0.2% vs CME's 0.2%

CME vs CBOE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CMECME Group Inc.
FY 2025
clearing and transaction fees
81.0%$5.3B
MarketData
12.3%$803M
OtherRevenue
6.7%$436M
CBOECboe Global Markets, Inc.
FY 2025
Transaction And Clearing Fees
76.3%$3.6B
Access And Capacity Fees
8.7%$409M
Market Data Fees
6.9%$327M
Regulatory Fees
6.1%$285M
Other Revenue
2.0%$96M

CME vs CBOE — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCMELAGGINGCBOE

Income & Cash Flow (Last 12 Months)

CME leads this category, winning 4 of 5 comparable metrics.

CME and CBOE operate at a comparable scale, with $6.5B and $4.7B in trailing revenue. CME is the more profitable business, keeping 62.0% of every revenue dollar as net income compared to CBOE's 23.3%.

MetricCME logoCMECME Group Inc.CBOE logoCBOECboe Global Marke…
RevenueTrailing 12 months$6.5B$4.7B
EBITDAEarnings before interest/tax$4.7B$1.6B
Net IncomeAfter-tax profit$4.2B$1.1B
Free Cash FlowCash after capex$4.4B$1.2B
Gross MarginGross profit ÷ Revenue+86.1%+48.9%
Operating MarginEBIT ÷ Revenue+64.9%+32.1%
Net MarginNet income ÷ Revenue+62.0%+23.3%
FCF MarginFCF ÷ Revenue+64.3%+24.5%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+21.4%+59.7%
CME leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

CME leads this category, winning 4 of 7 comparable metrics.

At 25.7x trailing earnings, CME trades at a 22% valuation discount to CBOE's 33.0x P/E. Adjusting for growth (PEG ratio), CBOE offers better value at 1.69x vs CME's 1.87x — a lower PEG means you pay less per unit of expected earnings growth.

MetricCME logoCMECME Group Inc.CBOE logoCBOECboe Global Marke…
Market CapShares × price$104.1B$36.0B
Enterprise ValueMkt cap + debt − cash$103.4B$35.5B
Trailing P/EPrice ÷ TTM EPS25.70x33.01x
Forward P/EPrice ÷ next-FY EPS est.23.49x27.43x
PEG RatioP/E ÷ EPS growth rate1.87x1.69x
EV / EBITDAEnterprise value multiple22.95x21.69x
Price / SalesMarket cap ÷ Revenue15.96x7.64x
Price / BookPrice ÷ Book value/share3.60x7.04x
Price / FCFMarket cap ÷ FCF24.81x31.25x
CME leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

CBOE leads this category, winning 6 of 9 comparable metrics.

CBOE delivers a 23.0% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $15 for CME. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to CBOE's 0.33x. On the Piotroski fundamental quality scale (0–9), CBOE scores 7/9 vs CME's 5/9, reflecting strong financial health.

MetricCME logoCMECME Group Inc.CBOE logoCBOECboe Global Marke…
ROE (TTM)Return on equity+15.3%+23.0%
ROA (TTM)Return on assets+2.2%+12.2%
ROICReturn on invested capital+10.2%+17.9%
ROCEReturn on capital employed+3.6%+22.7%
Piotroski ScoreFundamental quality 0–957
Debt / EquityFinancial leverage0.13x0.33x
Net DebtTotal debt minus cash-$666M-$532M
Cash & Equiv.Liquid assets$4.4B$2.2B
Total DebtShort + long-term debt$3.8B$1.7B
Interest CoverageEBIT ÷ Interest expense41.55x40.58x
CBOE leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CBOE leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CBOE five years ago would be worth $32,397 today (with dividends reinvested), compared to $16,437 for CME. Over the past 12 months, CBOE leads with a +49.7% total return vs CME's +5.5%. The 3-year compound annual growth rate (CAGR) favors CBOE at 37.0% vs CME's 19.8% — a key indicator of consistent wealth creation.

MetricCME logoCMECME Group Inc.CBOE logoCBOECboe Global Marke…
YTD ReturnYear-to-date+9.1%+38.9%
1-Year ReturnPast 12 months+5.5%+49.7%
3-Year ReturnCumulative with dividends+71.9%+157.3%
5-Year ReturnCumulative with dividends+64.4%+224.0%
10-Year ReturnCumulative with dividends+289.3%+476.8%
CAGR (3Y)Annualised 3-year return+19.8%+37.0%
CBOE leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CME and CBOE each lead in 1 of 2 comparable metrics.

CME is the less volatile stock with a -0.30 beta — it tends to amplify market swings less than CBOE's -0.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBOE currently trades 99.3% from its 52-week high vs CME's 87.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCME logoCMECME Group Inc.CBOE logoCBOECboe Global Marke…
Beta (5Y)Sensitivity to S&P 500-0.30x-0.27x
52-Week HighHighest price in past year$329.16$346.48
52-Week LowLowest price in past year$257.17$212.75
% of 52W HighCurrent price vs 52-week peak+87.1%+99.3%
RSI (14)Momentum oscillator 0–10046.073.6
Avg Volume (50D)Average daily shares traded2.2M868K
Evenly matched — CME and CBOE each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — CME and CBOE each lead in 1 of 2 comparable metrics.

Wall Street rates CME as "Hold" and CBOE as "Hold". Consensus price targets imply 11.7% upside for CME (target: $320) vs -13.9% for CBOE (target: $296). For income investors, CME offers the higher dividend yield at 3.81% vs CBOE's 0.79%.

MetricCME logoCMECME Group Inc.CBOE logoCBOECboe Global Marke…
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$320.25$296.00
# AnalystsCovering analysts3531
Dividend YieldAnnual dividend ÷ price+3.8%+0.8%
Dividend StreakConsecutive years of raises610
Dividend / ShareAnnual DPS$10.92$2.71
Buyback YieldShare repurchases ÷ mkt cap+0.3%+0.3%
Evenly matched — CME and CBOE each lead in 1 of 2 comparable metrics.
Key Takeaway

CME leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). CBOE leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.

Best OverallCME Group Inc. (CME)Leads 2 of 6 categories
Loading custom metrics...

CME vs CBOE: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is CME or CBOE a better buy right now?

For growth investors, Cboe Global Markets, Inc.

(CBOE) is the stronger pick with 15. 1% revenue growth year-over-year, versus 6. 4% for CME Group Inc. (CME). CME Group Inc. (CME) offers the better valuation at 25. 7x trailing P/E (23. 5x forward), making it the more compelling value choice. Analysts rate CME Group Inc. (CME) a "Hold" — based on 35 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CME or CBOE?

On trailing P/E, CME Group Inc.

(CME) is the cheapest at 25. 7x versus Cboe Global Markets, Inc. at 33. 0x. On forward P/E, CME Group Inc. is actually cheaper at 23. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Cboe Global Markets, Inc. wins at 1. 40x versus CME Group Inc. 's 1. 71x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — CME or CBOE?

Over the past 5 years, Cboe Global Markets, Inc.

(CBOE) delivered a total return of +224. 0%, compared to +64. 4% for CME Group Inc. (CME). Over 10 years, the gap is even starker: CBOE returned +476. 8% versus CME's +289. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CME or CBOE?

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 30β versus Cboe Global Markets, Inc. 's -0. 27β — meaning CBOE is approximately -11% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 33% for Cboe Global Markets, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CME or CBOE?

By revenue growth (latest reported year), Cboe Global Markets, Inc.

(CBOE) is pulling ahead at 15. 1% versus 6. 4% for CME Group Inc. (CME). On earnings-per-share growth, the picture is similar: Cboe Global Markets, Inc. grew EPS 44. 5% year-over-year, compared to 15. 4% for CME Group Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CME or CBOE?

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus 23. 3% for Cboe Global Markets, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 32. 1% for CBOE. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CME or CBOE more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Cboe Global Markets, Inc. (CBOE) is the more undervalued stock at a PEG of 1. 40x versus CME Group Inc. 's 1. 71x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, CME Group Inc. (CME) trades at 23. 5x forward P/E versus 27. 4x for Cboe Global Markets, Inc. — 3. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CME: 11. 7% to $320. 25.

08

Which pays a better dividend — CME or CBOE?

All stocks in this comparison pay dividends.

CME Group Inc. (CME) offers the highest yield at 3. 8%, versus 0. 8% for Cboe Global Markets, Inc. (CBOE).

09

Is CME or CBOE better for a retirement portfolio?

For long-horizon retirement investors, Cboe Global Markets, Inc.

(CBOE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 27), 0. 8% yield, +476. 8% 10Y return). Both have compounded well over 10 years (CBOE: +476. 8%, CME: +289. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CME and CBOE?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CME is a mid-cap income-oriented stock; CBOE is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CME

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 37%
Run This Screen
Stocks Like

CBOE

High-Growth Quality Leader

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 14%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CME and CBOE on the metrics below

Revenue Growth>
%
(CME: 6.4% · CBOE: 15.1%)
Net Margin>
%
(CME: 62.0% · CBOE: 23.3%)
P/E Ratio<
x
(CME: 25.7x · CBOE: 33.0x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.